Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDN   US24823Q1076

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on DENDREON CORPORATION
09/12 Feature - As music sales fall, sax player Kenny G turns to stockpicking
08/12 DENDREON : sinks after drugmaker warns of debt woes
08/11 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
08/06 Dendreon Names W. Thomas Amick President and Chief Executive Officer
08/06 DENDREON : Elects W. Thomas Amick as President and CEO
08/04 DENDREON : Taps W. Thomas Amick President
07/31 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
07/30 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
07/30 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
06/18 DENDREON : Termination of a Material Definitive Agreement (form 8-K)
06/09 DENDREON : Change in Directors or Principal Officers, Financial Statements and E..
06/09 DENDREON : Announces Leadership Transition
05/28 DENDREON : Treatment with PROVENGE® sipuleucel-T Induces Antigen Spread Associat..
05/21 DENDREON : Submission of Matters to a Vote of Security Holders (form 8-K)
05/21 DENDREON : Announces Presentation of PROVENGE® sipuleucel-T and DN24-02 Immuno-O..
05/20 DENDREON : Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associ..
05/20 DENDREON : to Present Provenge (sipuleucel-T) and DN24-02 Immuno- Oncology Data ..
05/15 DENDREON : Announces First Quarter 2014 Results
05/14 DENDREON : Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno..
05/08 DENDREON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
05/08 DENDREON : Results of Operations and Financial Condition, Financial Statements a..
05/08 DENDREON : Announces First Quarter 2014 Results
05/05DENDREON CORPORATION : quaterly earnings release
04/28 DENDREON : to Host Conference Call on May 8 to Announce First Quarter Financial ..
04/25 DENDREON : Posts Preliminary Data from Analysis of Phase II Stand Study
04/23 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® sipuleucel-T i..
04/17 DENDREON : Releases Preliminary Data from Analysis of Phase II Stand Study
04/11 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
03/12 DENDREON : Announces Fourth Quarter and 2013 Year End Results
03/12 DENDREON : Announces Plans to Make PROVENGE® Commercially Available in Europe
03/10 Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
03/07 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
03/06 DENDREON CORPORATION : Dendreon Reports Intent to Make Provenge Commercially Ava..
03/05 DENDREON CORPORATION : Patent Issued for Promiscuous HER-2/Neu CD4 T Cell Epitop..
03/04 DENDREON CORPORATION : Dendreon Corp. Assigned Patent
03/03 DENDREON CORPORATION : Dendreon Tests Resistance on Earnings Report, Provenge Ex..
03/03DJU.S. HOT STOCKS : Hot Stocks to Watch
03/03 Dendreon shares jump on news of prostate drug's European launch
03/03 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
03/03 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Results of Operation..
03/03 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
03/03 DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2013 Year End Resul..
02/26 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
02/25 DENDREON CORPORATION : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP ..
02/20 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
02/19 DENDREON CORPORATION : Patent Issued for Promiscuous PAP CD4 T Cell Epitopes
02/17 DENDREON CORPORATION : Dendreon Assigned Paten
02/14 DENDREON CORPORATION : Dendreon to Host Conference Call on March 3 to Announce F..
02/09 DENDREON CORPORATION : Dendreon Presents Provenge Data at Genitourinary Cancer S..
02/06 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
02/04 DENDREON CORPORATION : Dendreon Presents Provenge Data at Genitourinary Cancer S..
01/30 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
01/30 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
01/22 DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2013 Revenu..
01/14 DENDREON CORPORATION : Dendreon Releases Change to Presentation Date and Time at..
01/13 DENDREON CORPORATION : Dendreon spikes on strong 4Q revenue report
01/13 DENDREON CORPORATION : Dendreon spikes on strong 4Q revenue report
01/13 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
01/13 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Results of Operation..
01/13 DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2013 Revenu..
01/09 DENDREON CORPORATION : Dendreon Announces Change to Presentation Date and Time a..
01/07 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at J.P. Morgan He..
01/07 DENDREON CORPORATION : Dendreon Assigned Patent
2013 DENDREON CORPORATION : Dendreon Assigned Patent
2013 DENDREON CORPORATION : Dendreon to cut costs-and jobs
2013 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Other Events
2013 DENDREON CORPORATION : Clinical Studies Updates, and Stock Price Movements - Res..
2013 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Deutsche Bank ..
2013 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Deutsche Bank ..
2013 DENDREON CORPORATION : Dendreon Announces Third Quarter 2013 Results
2013 Dendreon Announces Third Quarter 2013 Results
2013 DENDREON CORPORATION : Histogenics Announces Appointment of John H. Johnson to I..
2013 Histogenics Announces Appointment of John H. Johnson to Its Board of Director..
2013 Histogenics Adds John H. Johnson to Its Board
2013 JOHNSON & JOHNSON : Histogenics Adds John H. Johnson to Its Board
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDN | US24823Q1076 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF